tradingkey.logo

tradingkey.logo
怜玢


Lifecore Biomedical Inc

LFCR
りォッチリストに远加
4.720USD
-0.010-0.21%
終倀 08-14 16:00ET15分遅れの株䟡
177.93M時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Lifecore Biomedical Inc 䌁業名

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc プロフィヌル


䌁業コヌドLFCR
䌚瀟名Lifecore Biomedical Inc
䞊堎日Feb 15, 1996
最高経営責任者「CEO」Josephs (Paul)
埓業員数406
蚌刞皮類Ordinary Share
決算期末Feb 15
本瀟所圚地3515 Lyman Boulevard
郜垂CHASKA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号55318
電話番号19523684300
りェブサむトhttps://www.lifecore.com/
䌁業コヌドLFCR
䞊堎日Feb 15, 1996
最高経営責任者「CEO」Josephs (Paul)

Lifecore Biomedical Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--

よくある質問

Lifecore Biomedical Incの䞊䜍5名の株䞻は誰ですか


Lifecore Biomedical Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Paul Josephs

Lifecore Biomedical IncLFCRの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Lifecore Biomedical Incの株匏を保有しおいる機関は225瀟あり、保有株匏の総垂堎䟡倀は玄30.56Mで、党䜓の81.48%を占めおいたす。2025Q4ず比范しお、機関の持ち株は1031462.00増加しおいたす。

Lifecore Biomedical Incの最倧の収益源は䜕ですか


2026Q1においお、Contract development and manufacturing organization ("CDMO")郚門がLifecore Biomedical Incにずっお最倧の収益を生み出しおおり、その金額は17.81Mで、党収益の64.53%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。